Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEVI STRAUSS & COLEVI · Entity 3651 | Director | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEVI STRAUSS & CO
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 181,261 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 54 · Balance 181,261 F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 14,463 |
Reported balance
After 2026-08-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-05 · Grant · Acquired 92 · Balance 14,463 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.
F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Revance Therapeutics, Inc.
Report date February 04, 2025 · Filed February 06, 2025
Section 16 reporting ended · disclosed 2025-02-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-02-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-02-04 · Other · Disposed 28,606 · Balance 15,000 F1: The reported securities were disposed of pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated as of December 7, 2024 (as subsequently amended, the "Merger Agreement"), by and among the Issuer, Crown Laboratories, Inc., a Delaware corporation ("Parent"), Reba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub," and together with Parent, the "Buyer Parties"), pursuant to which Merger Sub completed a cash tender offer (the "Offer") for all of the issued and outstanding shares of common stock, par value $0.001 per share (the "Shares"), of the Issuer at a purchase price of $3.65 per share, without interest, and subject to any applicable withholding taxes (the "Per Share Price"). These Issuer Shares were tendered for purchase pursuant to the Offer. Row 2 · 2025-02-06 · Disposition to issuer · Disposed 15,000 · Balance 0 F2: Pursuant to the Merger Agreement, each Issuer restricted stock award held by a non-employee member of the Issuer board then outstanding and not vested was canceled and converted into the right to receive the Per Share Price. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were disposed of pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated as of December 7, 2024 (as subsequently amended, the "Merger Agreement"), by and among the Issuer, Crown Laboratories, Inc., a Delaware corporation ("Parent"), Reba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub," and together with Parent, the "Buyer Parties"), pursuant to which Merger Sub completed a cash tender offer (the "Offer") for all of the issued and outstanding shares of common stock, par value $0.001 per share (the "Shares"), of the Issuer at a purchase price of $3.65 per share, without interest, and subject to any applicable withholding taxes (the "Per Share Price"). These Issuer Shares were tendered for purchase pursuant to the Offer.
F2: Pursuant to the Merger Agreement, each Issuer restricted stock award held by a non-employee member of the Issuer board then outstanding and not vested was canceled and converted into the right to receive the Per Share Price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:20 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 92 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-017422 · jberaud-form4_080526.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,463 Underlying: Class A Common Stock · 92 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:20 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-017422 · jberaud-form4_080526.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,261 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Read SEC document |
| May 06, 2026 Filed May 8, 2026 22:14 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 86 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-010380 · beraud-form4_050826.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,371 Underlying: Class A Common Stock · 86 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 06, 2026 Filed May 8, 2026 22:14 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-010380 · beraud-form4_050826.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,207 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 20:30 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 8,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-009019 · beraud-form4_042426.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,157 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:06 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 89 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-004640 · ownership.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,285 Underlying: Class A Common Stock · 89 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:06 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-26-004640 · ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,776 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:14 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 101 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-017124 · beraud-fom4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,196 Underlying: Class A Common Stock · 101 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:14 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-017124 · beraud-fom4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,701 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:53 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 97 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-011151 · beraud-fom4_081225.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,095 Underlying: Class A Common Stock · 97 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:53 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-011151 · beraud-fom4_081225.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,616 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Read SEC document |
| May 09, 2025 Filed May 13, 2025 01:57 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-005903 · beraud_form4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,998 Underlying: Class A Common Stock · 104 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 09, 2025 Filed May 13, 2025 01:57 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-005903 · beraud_form4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,534 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:19 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | ConversionClass B Common Stock · Derivative | 108,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-004779 · beraud_form4.xml · derivative · entry 3 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,894 Underlying: Class A Common Stock · 108,679 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · shares: Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:19 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 11,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-004779 · beraud_form4.xml · nonDerivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,446 F2 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:19 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | ConversionClass A Common Stock | 108,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-004779 · beraud_form4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:47 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 99 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001839882-25-013573 · beraud_form4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,573 Underlying: Class A Common Stock · 99 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:47 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001839882-25-013573 · beraud_form4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,077 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 15:49 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | Disposition to issuerCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-015341 · ownership.xml · nonDerivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, each Issuer restricted stock award held by a non-employee member of the Issuer board then outstanding and not vested was canceled and converted into the right to receive the Per Share Price. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 15:49 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | OtherCommon Stock | 28,606 | $3.65 | $104,411.90 |
DisclosureSEC source: 0000950170-25-015341 · ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: The reported securities were disposed of pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated as of December 7, 2024 (as subsequently amended, the "Merger Agreement"), by and among the Issuer, Crown Laboratories, Inc., a Delaware corporation ("Parent"), Reba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub," and together with Parent, the "Buyer Parties"), pursuant to which Merger Sub completed a cash tender offer (the "Offer") for all of the issued and outstanding shares of common stock, par value $0.001 per share (the "Shares"), of the Issuer at a purchase price of $3.65 per share, without interest, and subject to any applicable withholding taxes (the "Per Share Price"). These Issuer Shares were tendered for purchase pursuant to the Offer. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:52 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 106 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001839882-24-039788 · beraud_form4-111424.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,474 Underlying: Class A Common Stock · 106 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:52 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001839882-24-039788 · beraud_form4-111424.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,021 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| August 20, 2024 Filed Aug 23, 2024 00:46 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 93 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-010538 · beraud_ownership.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,368 Underlying: Class A Common Stock · 93 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 20, 2024 Filed Aug 23, 2024 00:46 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-010538 · beraud_ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,961 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:33 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 74 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-006713 · ownership.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,275 Underlying: Class A Common Stock · 74 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:33 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-006713 · ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,909 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| May 01, 2024 Filed May 3, 2024 08:42 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantStock Option (Right to buy) · Derivative | 23,458 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001479290-24-000084 · wk-form4_1714740158.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2034-04-30 F2 · derivative.exercise_date: The shares subject to the stock option shall vest on the earlier of (a) the one year anniversary, May 1, 2025 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to the Director's Continuous Service through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy. Read SEC document |
| May 01, 2024 Filed May 3, 2024 08:42 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001479290-24-000084 · wk-form4_1714740158.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,606 F1 · shares: Represents an annual restricted stock award (the "RSA") granted pursuant to the Company's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the earlier of (a) the one year anniversary, May 1, 2025 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to the Director's Continuous Service (as defined in the Company's 2014 Equity Incentive Plan (the "Plan")) through such vesting date. Read SEC document |
| April 24, 2024 Filed Apr 27, 2024 00:59 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 7,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-005255 · ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 23:24 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 88 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-002763 · beraud_form4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,201 Underlying: Class A Common Stock · 88 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 23:24 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-002763 · beraud_form4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,225 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 01:44 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 112 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-23-000150 · ownership.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,113 Underlying: Class A Common Stock · 112 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 01:44 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-23-000150 · ownership.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,156 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:33 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 113 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046788 · doc4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,001 Underlying: Class A Common Stock · 113 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:33 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046788 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,069 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| May 18, 2023 Filed May 23, 2023 00:58 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 117 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031617 · doc4.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,888 Underlying: Class B Common Stock · 117 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 18, 2023 Filed May 23, 2023 00:58 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031617 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,981 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. With respect to 38 of the DERs, the DERs shall vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant. With respect to 91 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Read SEC document |
| May 03, 2023 Filed May 5, 2023 17:13 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantStock Option (Right to buy) · Derivative | 5,915 | $0.00 Strike: $33.61 | $0.00 |
DisclosureSEC source: 0001479290-23-000058 · wf-form4_168332122145775.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,915 Underlying: Common Stock · 5,915 shares Expires 2033-05-02 F2 · derivative.exercise_date: The shares subject to the stock option shall vest on the earlier of (a) the one year anniversary, May 3, 2024 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to Ms. Beraud's Continuous Service through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy. Read SEC document |
| May 03, 2023 Filed May 5, 2023 17:13 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantCommon Stock | 3,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001479290-23-000058 · wf-form4_168332122145775.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,606 F1 · shares: Represents an annual restricted stock award (the "RSA") granted pursuant to the Company's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the earlier of (a) the one year anniversary, May 3, 2024 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to Ms. Beraud's Continuous Service (as defined in the Company's 2014 Equity Incentive Plan (the "Plan")) through such vesting date. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 22:39 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025261 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,852 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. F2 · balance_after: Includes 14,577 RSUs that may be settled in shares of Class A Common Stock, including RSUs previously issued in the form of dividend equivalent rights (DERs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. 4,326 of the RSUs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant and 10,251 of the RSUs vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the date of grant. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 02:56 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013528 · doc4.xml · nonDerivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,962 F2 · shares: Represents RSUs for Class A common stock constituting DERs issued pursuant to existing Class A common stock RSUs held by the holder (the "Underlying Class A RSUs"). DERs are issued with regard to the Underlying Class A RSUs, which bear dividend equivalent rights, when and as dividends were paid on the Issuer's Class A common stock. Each DER represents a contingent right to receive one share of Class A common stock. With respect to 28 of the DERs, the DERs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant of the corresponding Underlying Class A RSUs. With respect to 53 of the DERs, the DERs vest as to 100% of the shares on the earlier of the date before the next annual meeting of shareholders or the first anniversary of the date of grant of the corresponding Underlying Class A RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 02:56 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013528 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,707 F1 · shares: Represents restricted stock units (RSUs) for Class B common stock constituting dividend equivalent rights (DERs) issued pursuant to existing Class B common stock RSUs held by the holder (the "Underlying Class B RSUs"). DERs are issued with regard to the Underlying Class B RSUs, which bear dividend equivalent rights, when and as dividends were paid on the Issuer's Class B common stock. Each DER represents a contingent right to receive one share of Class B common stock, which is convertible into one share of Class A common stock at the option of the holder. The DERs have all vested. Certain of the Underlying Class B RSUs and the DERs issued pursuant thereto are subject to a deferral delivery feature. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:06 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058617 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,794 F1 · shares: With respect to 98 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 130 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 60 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:23 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046620 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,604 F1 · shares: With respect to 78 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 104 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 48 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| May 24, 2022 Filed May 25, 2022 22:34 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031970 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,452 F1 · shares: With respect to 77 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 142 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 33 of the DERs, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. With respect to 47 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
| May 04, 2022 Filed May 6, 2022 18:18 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantStock Option (Right to buy) · Derivative | 11,343 | $0.00 Strike: $18.12 | $0.00 |
DisclosureSEC source: 0001479290-22-000060 · wf-form4_165187549613174.xml · derivative · entry 2 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,343 Underlying: Common Stock · 11,343 shares Expires 2032-05-03 F2 · derivative.exercise_date: The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Ms. Beraud's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy. Read SEC document |
| May 04, 2022 Filed May 6, 2022 18:18 UTC | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantCommon Stock | 6,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001479290-22-000060 · wf-form4_165187549613174.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,072 F1 · shares: Represents an annual restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the one year anniversary, May 4, 2023, subject to Ms. Beraud's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date. Read SEC document |
| May 04, 2022 Filed May 13, 2022 18:08 UTC Amendment | Revance Therapeutics, Inc. RVNC · Entity 83521 | GrantStock Option (Right to buy) · Derivative | 10,756 | $0.00 Strike: $18.12 | $0.00 |
DisclosureSEC source: 0001479290-22-000065 · wf-form4a_165247967703233.xml · derivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,756 Underlying: Common Stock · 10,756 shares Expires 2032-05-03 F1 · derivative.exercise_date: The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Ms. Beraud's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 20:05 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025345 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,230 F1 · shares: The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next Annual Stockholder Meeting or the one-year anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:34 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013591 · doc4.xml · nonDerivative · entry 1 Beraud Jill · CIK 0001520061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,418 F1 · shares: With respect to 57 dividend equivalent rights (DER), each of those DERs represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. With respect to 105 of the DERs, the DERs shall vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. With respect to 24 of the DERs for Class A Common Stock, the DERs shall vest as to 100% of the shares on the first anniversary of the date of grant. F2 · price: Settlement of DER in connection with restricted stock units (RSU). The rights accrued when and as dividends were paid on the Issuer's Class A Common Stock or Class B Common Stock, as appropriate, and became exercisable proportionately with the RSU to which they are related. Each DER is the economic equivalent of one share of the Issuer's Class A Common Stock or Class B Common Stock, as appropriate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.